Teva, Orchid Settle Patent Dispute Over Azilect
Teva Pharmaceutical Industries Ltd. and Orchid Chemicals & Pharmaceuticals Ltd. have reached a settlement in patent and antitrust litigation over Teva's Parkinson's disease drug Azilect, resulting in dismissal of all claims...To view the full article, register now.
Already a subscriber? Click here to view full article